Feb 13 Injectable drug provider Hospira Inc
on Wednesday reported a profit for the fourth quarter
versus a year-earlier loss as its sales increased more than 8
Net income was $5.3 million, or 3 cents per share, in the
latest quarter, compared with a net loss of $214.0 million, or
$1.30 per share, in the year-earlier period.
Adjusted earnings were 55 cents per share. On that basis,
analysts on average were expecting earnings per share of 54
Net sales jumped to $1.1 billion in the quarter from $1.0
billion a year before.